DIANNA BROWN: Open Payments
NPI 1063193399 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$272 in 12 payments from 6 companies in 2025. Trend: 2023 $29 · 2024 $277 · 2025 $272
Food & beverage: $272
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 3 | $76 |
| E.R. Squibb & Sons, L.L.C. | 3 | $67 |
| Esperion Therapeutics, Inc. | 2 | $40 |
| Novo Nordisk Inc | 2 | $38 |
| Inspire Medical Systems, Inc. | 1 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: OPSUMIT, CAMZYOS, NEXLETOL, Wegovy, INSPIRE, OPSYNVI, ELIQUIS, JARDIANCE.
Industry payments across MD — which companies pay providers there.
